Zaffre Investments
Overview
Zaffre Investments is a venture capital firm strategically focused on improving the way health care is delivered to consumers . They fund solutions that have a tangible impact on access, affordability, equity, and experience by solving for current barriers to high-value health care . The firm invests in seed, early, late and growth stages . It seeks to invest in consumer solution and healthcare sectors .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Foodsmart | Jan 2018 | Series B Extension | Lead |
| Brightline | Jun 2021 | Series B | - |
| InfoBionic.Ai | Oct 2023 | Series D | Co-investor |
| InformedDNA | Jul 2014 | VC Round | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Zaffre Investments based?
Zaffre Investments is headquartered in Boston, Massachusetts, United States.
When was Zaffre Investments founded?
Zaffre Investments was founded in 2014.
How many portfolio companies does Zaffre Investments have?
Zaffre Investments has 6 portfolio companies in Caplight's dataset.
What are some companies in Zaffre Investments's portfolio?
Portfolio companies visible on Caplight include Foodsmart, Brightline, InfoBionic.Ai, InformedDNA.
What was Zaffre Investments's most recent investment shown here?
Zaffre Investments's most recent investment in this portfolio sample was in InfoBionic.Ai in 2023.
What sectors does Zaffre Investments focus on?
Zaffre Investments focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software.
What company stages does Zaffre Investments focus on?
Zaffre Investments typically invests at the Mid stage.
What is Zaffre Investments's AUM?
Zaffre Investments's assets under management are estimated between $50.0M and $100.0M.